SPUR Trademark

Trademark Overview


On Tuesday, March 4, 2025, a trademark application was filed for SPUR with the United States Patent and Trademark Office. The USPTO has given the SPUR trademark a serial number of 79422215. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Thursday, February 12, 2026. This trademark is owned by Spur Therapeutics Limited. The SPUR trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical and medical preparations for the treatment of metabolic, cardiovascular, neurological and central nervous systems disorders; Pharmaceutical and medical preparations for gene therapy for the treatment of metabolic, cardiovascular, neurological and central nervous systems disorders; Pharmaceutical and medical preparations for Gaucher disease and Parkinson's disease; Pharmaceutical and medical preparations for gene therapy for the treatment of Gaucher disease and Parkinson's disease; all of the aforementioned for human use.

Pharmaceutical research and development services; biological, medical, preclinical and clinical research and development in the fields of gene therapy and preparations for the treatment of metabolic, cardiovascular, neurological and central nervous systems disorders; biological, medical, preclinical and clinical research and development in the fields of gene therapy and preparations for the treatment of Gaucher disease and Parkinson's disease; all of the aforementioned being related to human health.
spur

General Information


Serial Number79422215
Word MarkSPUR
Filing DateTuesday, March 4, 2025
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateThursday, February 12, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical and medical preparations for the treatment of metabolic, cardiovascular, neurological and central nervous systems disorders; Pharmaceutical and medical preparations for gene therapy for the treatment of metabolic, cardiovascular, neurological and central nervous systems disorders; Pharmaceutical and medical preparations for Gaucher disease and Parkinson's disease; Pharmaceutical and medical preparations for gene therapy for the treatment of Gaucher disease and Parkinson's disease; all of the aforementioned for human use.
Goods and ServicesPharmaceutical research and development services; biological, medical, preclinical and clinical research and development in the fields of gene therapy and preparations for the treatment of metabolic, cardiovascular, neurological and central nervous systems disorders; biological, medical, preclinical and clinical research and development in the fields of gene therapy and preparations for the treatment of Gaucher disease and Parkinson's disease; all of the aforementioned being related to human health.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 24, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, April 24, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSpur Therapeutics Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Thursday, April 24, 2025SN ASSIGNED FOR SECT 66A APPL FROM IB
Wednesday, April 30, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, April 30, 2025APPLICATION FILING RECEIPT MAILED
Tuesday, August 5, 2025ASSIGNED TO EXAMINER
Wednesday, August 6, 2025NON-FINAL ACTION WRITTEN
Thursday, August 7, 2025NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, September 16, 2025REFUSAL PROCESSED BY MPU
Wednesday, September 17, 2025NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, October 3, 2025REFUSAL PROCESSED BY IB
Thursday, February 12, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 12, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 12, 2026TEAS/EMAIL CORRESPONDENCE ENTERED